This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2021 report.Search in Google Scholar
Ghidul ENSP pentru tratamentul dependen ei de tutun. European Network for Smoking and Tobacco Prevention. 2019.Search in Google Scholar
Ulmeanu R, Fildan AP, Oancea C, Mihăl an F. Recomandări de diagnostic și tratament în bronhopneumopatia obstructivă cronică. Editura Medicală, București. 2019. p 15-16.Search in Google Scholar
Bălă GP, Râjnoveanu RM, Tudorache E, et al. Air pollution exposure- the (in)visible risk factor for respiratory disease. Environ Sci Pollut Res Int. 2021; 28(16): 19615-19628.Search in Google Scholar
Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: Impact, measurement and mechanisms. Respirology. 2015; 20(8):1160-71.Search in Google Scholar
Hlapcic I, Belamaric D, Bosnar M, et al. Combination of Systemic Inflammatory Biomarkers in Assessment of Chronic Obstructive Pulmonary Disease: Diagnostic Performance and Identification of Networks and Clusters. Diagnostics (Basel). 2020; 10(12): 1029.Search in Google Scholar
Wang Y, Xu J, Meng Y, Adcock IM, Yao X. Role of inflammatory cells in airway remodeling in COPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:3341-3348.Search in Google Scholar
Chan SMH, Selemidis S, Bozinovski S, Vlahos R. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies. Pharmacol Ther. 2019; 198:160-188.Search in Google Scholar
Córdoba-Lanús E, Baz-Dávila R, Espinoza-Jiménez A, et al. IL-8 gene variants are associated with lung function decline and multidimensional BODE index in COPD patients but not with disease susceptibility: a validation study. COPD. 2015; 12(1):55-61.Search in Google Scholar
Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010; 7(3):e1000220.Search in Google Scholar
Che L, Yu C, Chen G, et al. The Inflammatory Response Induced by RELMβ Upregulates IL-8 and IL-1β Expression in Bronchial Epithelial Cells in COPD. Int J Chron Obstruct Pulmon Dis. 2021; 16:2503-2513.Search in Google Scholar
Oishi K, Matsunaga K, Shirai T, et al. Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease. J Clin Med. 2020; 9(8):2670.Search in Google Scholar
De Llano LP, Cosío BG, Iglesias A, et al. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach. Int J Chron Obstruct Pulmon Dis. 2018; 13:591-601.Search in Google Scholar
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017; 195(5):557–82.Search in Google Scholar
Perera WR, Hurst JR, Wilkinson TMA, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 2007; 29(3): 527–34.Search in Google Scholar
Perotin JM, Dury S, Renois F, et al. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J Med Virol. 2013; 85(5): 866–73.Search in Google Scholar
Ritchie AI, Wedzicha JA. Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations. Clin Chest Med. 2020; 41(3):421-438.Search in Google Scholar
Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000; 55: 114–120.Search in Google Scholar
Rosales C. Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types. Front. Physiol. 2018; 9:113.Search in Google Scholar
Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59(7):574-80.Search in Google Scholar
Katsiki N, Stoian AP, Steiropoulos P, et al. Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview. Metabolites. 2020; 10(11):465.Search in Google Scholar
Miller J, Edwards LD, Agusti A, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013; 107: 1376–1384.Search in Google Scholar
Williams MC, Murchison JT, Edwards LD, et al. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax. 2014; 69: 718–723.Search in Google Scholar
Rabe KF, Hurst JR, Suissa S. Cardiovascular disease and COPD: dangerous liaisons? Eur Respir Rev. 2018; 27(149):180057.Search in Google Scholar
Zhou JS, Li ZY, Xu XC, et al. Cigarette smoke-initiated autoimmunity facilitates sensitisation to elastin-induced COPD-like pathologies in mice. Eur Respir J. 2020; 56(3):2000404.Search in Google Scholar
Andreeva E, Pokhasnikova M, Lebedev A, et al. Inflammatory parameters and pulmonary biomarkers in smokers with and without chronic obstructive pulmonary disease (COPD). J Thorac Dis. 2021; 13(8):4812-4829.Search in Google Scholar
Gao J, Zhan B. The effects of Ang-1, IL-8 and TGF-β1 on the pathogenesis of COPD. Mol Med Rep. 2012; 6(5):1155-9.Search in Google Scholar
Gea J, Pascual S, Casadevall C, et al. Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J Thorac Dis. 2015; 7(10):E418-38.Search in Google Scholar
Crul T, Spruit MA, Gayan-Ramirez G, et al. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest. 2007; 37(11):897-904.Search in Google Scholar
Henrot P, Dupin I, Schilfarth P, et al. Main Pathogenic Mechanisms and Recent Advances in COPD Peripheral Skeletal Muscle Wasting. Int J Mol Sci. 2023; 24(7):6454.Search in Google Scholar
Akpınar EE, Akpınar S, Ertek S, et al. Systemic inflammation and metabolic syndrome in stable COPD patients. Tuberk Toraks. 2012; 60(3):230-7.Search in Google Scholar
Minas M, Kostikas K, Papaioannou AI, et al. The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities. COPD. 2011; 8(6):414-20.Search in Google Scholar
Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011; 121(6):2094-101.Search in Google Scholar
Watz H, Waschki B, Kirsten A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest. 2009; 136(4):1039-1046.Search in Google Scholar
Passey SL, Hansen MJ, Bozinovski S, et al. Emerging therapies for the treatment of skeletal muscle wasting in chronic obstructive pulmonary disease. Pharmacol Ther. 2016; 166:56-70.Search in Google Scholar
Trøseid M, Lappegård KT, Claudi T, et al. Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Heart J. 2004; 25(4):349-55.Search in Google Scholar
De Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008; 582(1):97-105.Search in Google Scholar
Gerhardt CC, Romero IA, Cancello R et al. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol. 2001; 175:81–92.Search in Google Scholar
Sarir H, Mortaz E, Karimi K, et al. Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages. J Inflamm (Lond). 2009; 6:12.Search in Google Scholar
Kotlyarov S. High-Density Lipoproteins: A Role in Inflammation in COPD. Int J Mol Sci. 2022; 23(15):8128.Search in Google Scholar
